RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study.

PLoS One 2012 27;7(12):e52374. Epub 2012 Dec 27.

Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France.

Background: Although inherited breast cancer has been associated with germline mutations in genes that are functionally involved in the DNA homologous recombination repair (HRR) pathway, including BRCA1, BRCA2, TP53, ATM, BRIP1, CHEK2 and PALB2, about 70% of breast cancer heritability remains unexplained. Because of their critical functions in maintaining genome integrity and already well-established associations with breast cancer susceptibility, it is likely that additional genes involved in the HRR pathway harbor sequence variants associated with increased risk of breast cancer. RAD51 plays a central biological function in DNA repair and despite the fact that rare, likely dysfunctional variants in three of its five paralogs, RAD51C, RAD51D, and XRCC2, have been associated with breast and/or ovarian cancer risk, no population-based case-control mutation screening data are available for the RAD51 gene. We thus postulated that RAD51 could harbor rare germline mutations that confer increased risk of breast cancer.

Methodology/principal Findings: We screened the coding exons and proximal splice junction regions of the gene for germline sequence variation in 1,330 early-onset breast cancer cases and 1,123 controls from the Breast Cancer Family Registry, using the same population-based sampling and analytical strategy that we developed for assessment of rare sequence variants in ATM and CHEK2. In total, 12 distinct very rare or private variants were characterized in RAD51, with 10 cases (0.75%) and 9 controls (0.80%) carrying such a variant. Variants were either likely neutral missense substitutions (3), silent substitutions (4) or non-coding substitutions (5) that were predicted to have little effect on efficiency of the splicing machinery.

Conclusion: Altogether, our data suggest that RAD51 tolerates so little dysfunctional sequence variation that rare variants in the gene contribute little, if anything, to breast cancer susceptibility.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0052374PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531476PMC
July 2013
12 Reads

Publication Analysis

Top Keywords

breast cancer
36
cancer susceptibility
12
breast
10
cancer
10
family registry
8
cancer family
8
sequence variants
8
data rad51
8
sequence variation
8
hrr pathway
8
germline mutations
8
risk breast
8
increased risk
8
variants
6
rad51
6
rare
6
plays central
4
exons proximal
4
despite fact
4
missense substitutions
4

References

(Supplied by CrossRef)
Rare variants in the ATM gene and risk of breast cancer
DE Goldgar et al.
Breast Cancer Res 2011

Similar Publications